ImmunoServ awarded Welsh Government innovation funding

ImmunoServ are delighted to be awarded funding from the Welsh Government SMART Flexible Innovation Support scheme. This award will expand our portfolio of services to help meet growing demand for monitoring cellular immune responses. In addition, it will support the development of ImmunoServ’s own T cell assays for use across a range of diseases and upcoming population immunity studies.

Project manager of this study Dr Martin Scurr (CSO, ImmunoServ) added: “We are very grateful for this support from the Welsh Government. It is particularly gratifying to receive backing for ImmunoServ’s vision to promote public health through the development of high-quality immunological products and services.”